Nonspecific interstitial pneumonia/fibrosis (NSIP) was first described by Katzenstein and Fiorelli in 1994 (Am J Surg Pathol 18: 136-147). Many reports have described that corticosteroids are effective for NSIP.Wedescribe a case of group II idiopathic NSIP in whomcyclophosphamide was administered since the initial response to corticosteroids had been insufficient. Lung biopsy was performed by video-assisted thoracoscopic surgery and NSIP was diagnosed pathologically, clinically and radiologically. Although the initial response to corticosteroids was insufficient, interstitial infiltrates on chest computed tomography improved dramatically after adding intravenous cyclophosphamide followed by oral cyclophosphamide. This case demonstrates that the addition of cyclophosphamide to corticosteroids might be a useful treatment for patients with NSIP. (Internal Medicine 41 : 867-870, 2002) 
Introduction
Nonspecific interstitial pneumonia/fibrosis (NSIP) was first described by Katzenstein and Fiorelli in 1994 (1) . NSIP has also been reported to be associated with collagen vascular disorders (1).
Many reports have described that corticosteroids are effective for NSIP (1) (2) (3) (4) (5) (6) (7) (8) (9) . In addition, although other immunosuppressants (such as cyclophosphamide or azathioprine), have been used in patients with NSIPin whomcorticosteroids were ineffective, the role of these immunosuppressants in patients with NSIP has not been clarified (1, (5) (6) (7) (8) (9) .
In the present report, we describe a case of NSIP group II in whominterstitial infiltrates on chest computed tomography (CT) were resolved by cyclophosphamide added to corticosteroid treatment.
Case Report
A 48-year-old woman; a licensed cook, attended the outpatient clinic of the Mitoyo General Hospital with a non-productive cough and fever. Although she was treated with antibiotics, her symptomsworsened and she went to the emergency department due to dyspnea; she was then admitted to our hospital. She had not experienced any risk factors for occupational or environmental exposure to toxic materials, nor did she have hypersensitivity pneumonitis. She was a non-smoker and her previous medical history was not remarkable. There were no abnormal findings on chest computed tomography which had been taken 3-years earlier. On physical examination, she was febrile and cyanotic with a respiratory rate of 25 per minute. Her blood pressure was 114/62 mmHg.She had tachycardia without arrhythmia. Bibasilar inspiratory fine crackles were ausculated. Laboratory data showed a normal blood cell count. The electrolyte, renal and liver test was normal except for AST (5 1 IU//). LDHand CRPwere elevated. Autoantibodies; antinuclear antibody, rheumatoid factor, anti-single stranded DNA antibody, anti-double stranded DNAantibody, anti-RNP antibody, anti-Sm antibody, anti-Scl70 antibody or anti-Jo1 antibody were all negative. Arterial blood gas analysis showed mission, and bronchoalveolar lavage (BAL) and transbronchial lung biopsy (TBLB) were performed from the right middle lobe. BALfluid showed an increased cell number (1,400 cells/ jliI), lymphocytes predominance (59%), eosinophil (7%), neutrophil (17%) and decreased CD4/CD8 ratio (0.3 1). Pathological evaluation of the specimen obtained by TBLBrevealed compatibility with interstitial pneumonia. Based on radiological and pathological findings, acute interstitial pneumonia (AIP), bronchiolitis obliterance organizing pneumonia (BOOP), eosinophilic pneumonia, NSIP, or atypical pneumonia were considered. Therefore, intravenous methylprednisolone ( 1 g/ day, for 3 days) followed by oral prednisolone and intravenous minocycline were administered (Fig. 2 ). Dyspnea and fever were improved and oral prednisolone was reduced gradually.
However, at the time of prednisolone of 25 mg/day, she became febrile and her chest computed tomography findings were not so improved (Fig. IB) . In addition, arterial blood gas analysis was deteriorated (PaCO2 30.7 Torr, PaO2 55.0 Torr). To make the definite pathological diagnosis, lung biopsy was performed under video-assisted thoracoscopic surgery (VATS). Histological examination revealed intraluminal growth of connective tissues which were widely adherent to alveolar walls, accumulation of xanthoma cells in alveolar cavity, and diffuse infiltration of lymphocytes (Fig. 3) . Since pathological, clinical and radiological diagnosis was NSIP group II, intravenous corticosteroids were administered again. However,while receiving prednisolone (25 mg/day), she became febrile again. In addition, arterial blood gas analysis was deteriorated again (PaCO2 33.4 Torr, PaO2 58.2 Torr). Therefore, we added intravenous cyclophosphamide (800 mg/body x 3, weekly) followed by oral cyclophosphamide ( 100 mg/body). Three months after adding cyclophosphamide, her chest computed tomography revealed that interstitial infiltrates had dramatically improved (Fig. 1 C) .
Her arterial blood gas analysis became normal which showed cyclophosphamide to corticosteroids. Although several immunosuppressants were used in patients with NSIP associated with collagen vascular disorders, this is the first report which describes the clinical course of an idiopathic NSIP patient in whom cyclophosphamideadding to corticosteroids was very effective.
NSIP was first described by Katzenstein and Fiorelli in 1994 (1) . In the initial description of this pattern of interstitial pneumonia, NSIP was proposed as a diagnosis in specimens with findings that did not conform to the typical findings seen in usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), AIP, or BOOP(1). In addition, it has been reported that NSIP is associated with collagen vascular disorders (1).
Wereviewed the clinical features of NSIP described in several reports (Table 1 ). There have been many reports of patients with NSIP in whomcorticosteroids or other immunosuppressants were used ( 1-10). Although several immunosuppressants (such as, cyclophosphamide or azathioprine), were used for patients with NSIPin whominitial response to corticosteroids was not sufficient, the usefulness of these immunosuppressants for NSIP has not been established (1, (5) (6) (7) (8) (9) . Ogasawaraet al have reported successful treatment with lowdose cyclosporin A (1 mg/kg/day) in a patient with interstitial pneumonitis associated with Sjogren's syndrome who was resistant to corticosteroids (1 1). In addition, in NSIP associated with collagen vascular diseases, cyclophosphamide is frequently used. However, there has been no report that describes a case of idiopathic NSIP in whominterstitial infiltrates were resolved by adding cyclophosphamide to corticosteroids. The present case, however, demonstrates that cyclophosphamide added to corticosteroid therapy might be a useful treatment for patients NSIRFurther studies are necessary to evaluate the role of cyclophosphamide in the treatment of NSIR
